Publications
- Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome2016 | Faculty of Medicine in Hradec Králové
- Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 20212023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple Sclerosis2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
- The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease2023 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Interferon beta-1a vs. glatiramer acetate: changes of innate immunity in a group of women with multiple sclerosis2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Erratum - Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Im-munity in a Group of Women with Multiple Sclerosis (vol 86, pg 334, 2023)2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Long--term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data2023 | Faculty of Medicine in Hradec Králové
- Rimegepant in the treatment of migraine conditions2023 | Faculty of Medicine in Hradec Králové
Loading network view...